Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 16/20 | 0.52 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28873208 | 0.97 | TLR7 (0.55) | TLR7TLR8ADORA3ADORA2AADORA2B | |
| SCHEMBL854401 | 0.90 | TLR7 (0.42) | TLR7TLR8CYP1A2 | |
| SCHEMBL854702 | 0.85 | HRH1 (0.46) | TLR7TLR8 | |
| SCHEMBL3695327 | 0.82 | TLR7 (0.68) | TLR7TLR8 | |
| SCHEMBL30035529 | 0.82 | TLR7 (0.51) | TLR7 | |
| SCHEMBL853783 | 0.81 | TLR7 (0.45) | TLR7TLR8 | |
| SCHEMBL30036873 | 0.80 | TLR7 (0.56) | TLR7TLR8 | |
| SCHEMBL28873197 | 0.80 | TLR7 (0.56) | TLR7 | |
| SCHEMBL854178 | 0.80 | ALDH1A1 (0.51) | TLR7TLR8ADORA3ADORA2AADORA1 | |
| SCHEMBL853209 | 0.79 | DHFR (0.59) | TLR7TLR8ADORA3ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432768-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES | AstraZeneca AB (SE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010133885-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | WO | disclosed |